Guy MORDRET, PhD, is currently the CEO of Anaximandre a company specialized in IT solutions for biotechnologies and life sciences companies. Former scientist, he conducted research on cell cycle control and cancer. He is also a European Expert (bioinformatics) for DG CONNECT of European Commission since 2005.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.